Home  >  Products  >  KIR2DL4 (killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4) Blocking Peptide (the middle region of protein) (100ug)
KIR2DL4 (killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4) Blocking Peptide (the middle region of protein) (100ug)

KIR2DL4 (killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4) Blocking Peptide (the middle region of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KIR2DL4 antibody (Catalogue #: ARP42025_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP42025
Size: 100 ug
Weight: 30kDa
Gene: 3805
Format: Lyophilized powder
Target: Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the
Alternative names: CD158D; G9P; KIR103; KIR103AS
See Full Product Listings >